Evaluation of antibiofilm agents for treatment of cystic fibrosis-related chronic rhinosinusitis

0Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Key points: Treatment of cystic fibrosis-related chronic rhinosinusitis should target sinonasal biofilms. NaHCO3 salts with/without xylitol have limited antibiofilm properties, whereas rhDNAse has not. Phage effectivity varies and depends on the phage and the combination with antibiotics.

Cite

CITATION STYLE

APA

Uyttebroek, S., Dupont, L., Wagemans, J., Lavigne, R., Merabishvili, M., Coenye, T., & Van Gerven, L. (2025). Evaluation of antibiofilm agents for treatment of cystic fibrosis-related chronic rhinosinusitis. International Forum of Allergy and Rhinology, 15(1), 73–76. https://doi.org/10.1002/alr.23441

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free